Search Results
May 30, 2026, 06:36 ET Chandigarh University Research Scientist Receives Startup Research Grant of Rs 24 Lakhs
productivity, grain quality and long-term food security in the face of climate change."Dr Vijay Gahlaut was assisted in the project by Praveen Kumar, a PhD scholar in Biotechnology at UIBT Chandigarh University.Dr Gahlaut added, "Our team's preliminary results are already pointing to practical ways
More news about: Chandigarh University
May 29, 2026, 17:48 ET Researchers From NYU Langone Health's Perlmutter Cancer Center Present Latest Findings at 2026 ASCO Annual Meeting
David R. Wise, MD, PhD, an associate professor of medicine and urology and the service chief of the
More news about: NYU Langone Health System
May 29, 2026, 15:25 ET Leica Biosystems and CellCarta Expand Collaborative Companion Diagnostic Development Model to Accelerate Commercialization Globally
www.leicabiosystems.com. Media ContactsCellCartaStéphanie Bussières-Marmen, PhDDirector, Global [email protected]
More news about: CellCarta
May 29, 2026, 08:02 ET Dutch Bros Community Reaches $20 Million in Total Lifetime Donations to Muscular Dystrophy Association During 19th Annual Drink One For Dane Day of Giving
impact."When I visited my local Dutch Bros for Drink One for Dane this year, I felt the heart behind this partnership immediately," said Sharon Hesterlee, PhD, President and CEO of the Muscular Dystrophy Association. "From the broistas to the leadership team, Dutch Bros has built a culture where people truly
More news about: Dutch Bros Coffee
May 29, 2026, 08:00 ET AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia
regimens have demonstrated a favorable efficacy and safety profile in the first-line setting for chronic lymphocytic leukemia," said Svetlana Kobina, MD, PhD, vice president, global medical affairs, oncology, AbbVie. "The inclusion of additional fixed-duration, chemotherapy-free, oral VENCLYXTO combinations
More news about: AbbVie
May 29, 2026, 08:00 ET AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia
regimens have demonstrated a favorable efficacy and safety profile in the first-line setting for chronic lymphocytic leukemia," said Svetlana Kobina, MD, PhD, vice president, global medical affairs, oncology, AbbVie. "The inclusion of additional fixed-duration, chemotherapy-free, oral VENCLYXTO combinations
More news about: AbbVie
May 29, 2026, 05:00 ET American Council of Learned Societies Awards 2026 ACLS Leading Edge Fellowships
In fall 2026, 14 fellows will begin two-year positions designed to take advantage of the numerous skills of PhD humanists while contributing to the work of host organizations. Awardees earned PhDs from 13 universities and represent a wide array of disciplines in
More news about: American Council of Learned Societies
May 28, 2026, 23:31 ET /C O R R E C T I O N -- People Science, Inc./
and discs, according to a new consumer study released today by Saalt and People Science. The study, conducted in collaboration with Marybec Griffin, PhD, is the first in the U.S. to link reusable menstrual products to statistically significant improvements in user-reported cramping, fatigue, bloating,
More news about: People Science, Inc.
May 28, 2026, 19:26 ET Phanes Therapeutics Announces Updated Phase 2 Clinical Trial Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline Treatment of Metastatic PDAC at the 2026 ASCO Annual Meeting
significant because PDAC is considered a 'cold tumor' to ICIs. Now we have the opportunity to target PDAC with a new class of immunotherapy," said Ming Wang, PhD, MBA, Founder and CEO of Phanes. "The enrollment at the 3 mg/kg dose level is progressing rapidly and we hope to see efficacy data in the second half
More news about: Phanes Therapeutics, Inc.
May 28, 2026, 16:05 ET Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference
technologies to established tumor biology to efficiently deliver improved antibody drug conjugate (ADC) cancer treatments, today announced Dave Lennon, PhD, President and CEO, will present at the Jefferies 2026 Global Healthcare Conference in New York City, NY on Thursday, June 4 at 8:10 AM ET.A live
More news about: Whitehawk Therapeutics, Inc.
May 28, 2026, 15:21 ET What If You're Dreaming More Than You Realize?
author Lisa Feldman Barrett, PhD, neuroscientist and NYU Dean Wendy Suzuki, PhD, futures designer Nick Foster, RDI, sleep psychologist Jade Wu, PhD, broadcaster and author Krista Tippett, journalist and author Eliot Stein, medical anthropologist and author Theresa MacPhail, PhD, poet, activist, and author
More news about: Unlikely Collaborators
May 28, 2026, 14:07 ET John Joyoprayitno, Sarah Mayes, PhD, and Dan Peterson, MD Named Finalists for Entrepreneur Of The Year® 2026 Gulf South Award
May 28, 2026 /PRNewswire/ -- Alafair Biosciences today announced that co-founders John Joyoprayitno, Sarah Mayes, PhD, and Dan Peterson, MD are named finalists for the Entrepreneur Of The Year® 2026 Gulf South Award by Ernst & Young LLP (EY US).
More news about: Alafair Biosciences, Inc.
May 28, 2026, 13:44 ET Scientific Systems Welcomes Dr. Dan "Animal" Javorsek to Leadership Team and Expands Growth Organization with Two Strategic Hires
company's capacity to deliver advanced, multi–domain autonomous capabilities in support of the warfighter. Leading this cohort is Dan "Animal" Javorsek, PhD, a recognized expert in autonomy for defense systems, who joins the company's leadership team as Chief Strategy Officer. He has previously held senior
More news about: Scientific Systems Inc.
May 28, 2026, 13:13 ET J.P. Morgan Asset Management Launches JPMorgan Managed Futures Plus ETF (JPFP) on Nasdaq
Morgan Asset Management's $529 billion Multi-Asset Solutions group2. The portfolio management team includes Dr. Yazann Romahi, PhD, CFA, Chief Investment Officer for Quantitative Solutions, Kartik Aiyar, Dr. Wei (Victor) Li, and Garrett Norman. Together, the team brings decades of
More news about: J.P. Morgan Asset Management
May 28, 2026, 13:00 ET Clinical Study Confirms Trace Minerals' ZeroLyte Hydrates Two Times Faster Than Water
Stavros Kavouras, PhD, professor and director of the Hydration Science Lab, the study found that Trace Minerals' award-winning
More news about: Trace
May 28, 2026, 12:48 ET NURSE CAPITAL PILOTS NEW INITIATIVE FOR NURSE FOUNDERS TO DEVELOP THEIR INNOVATIONS INTO SCALABLE, INVESTOR-READY BUSINESSES
securing grant funding, raising small angel investments, piloting products, and winning pitch competitions to fund their startups," said Beth A. Brooks, PhD, RN, FACHE, Co-founder and General Partner of Nurse Capital. "Yet for many of these founders, there exists a significant gap between early innovation
More news about: Nurse Capital
May 28, 2026, 11:32 ET NeuLogiq® Platform Helps Confirm No Evidence of Psychotomimetic, Hallucinatory, or Dissociative Effects in a Phase 1b Study of a Novel Neuroplastogen Developed for Major Depressive Disorder
Putative Biomarkers of Neuroplasticity for the Novel Neuroplastogen Zalsupindole (DLX-001) in Major Depressive Disorder," was presented by Retsina Meyer, PhD, Head of Corporate Strategy at Delix Therapeutics, and Eliseo Salinas, MD, MSc, Head of Research & Development.Delix deployed the NeuLogiq
More news about: Cumulus Neuroscience
May 28, 2026, 10:00 ET Circulate Health Study Finds Plasma Exchange Removes Microplastics from the Human Bloodstream
toxicology standpoint, it's important to understand how persistent environmental exposures contribute to overall biological burden," said Matthew Campen, PhD, Scientific Advisor to Circulate Health and Director of the New Mexico Center for Metals in Biology and Medicine. "Studying microplastics directly in
More news about: Circulate Health
May 28, 2026, 10:00 ET Montefiore Einstein obtiene $8 millones en subvenciones federales y municipales para reforzar el vínculo entre la figura paterna y los hijos
implicados en la vida de sus hijos, ofreciéndoles apoyo emocional, organizando actividades, supervisándolos y acompañándolos", asegura Moshe Moeller, PhD, Director Asociado del programa HERO Dads. "Gracias a nuestra nueva oferta de programas centrada en la seguridad emocional, el refuerzo de la confianza,
More news about: Montefiore Health System
May 28, 2026, 09:56 ET Nootropics Depot CEO Challenges Conventional Electrolyte Science In New White Paper
(COAs), and lab testing results available on every product page. In addition, they have formed a Scientific Advisory Board with board certified doctors, PhD researchers, and botanists to ensure that consumers can trust that scientific rigor is being upheld in everything they do. Nootropics Depot's newly redesigned
More news about: Nootropics Depot
May 28, 2026, 09:15 ET CULINARY INSTITUTE OF AMERICA INTRODUCES FOOD IS LIFE, FOOD IS HEALTH SUMMIT
and policy experts, registered dietitian nutritionists, and researchers, including Sara Bleich, PhD, professor of public policy at Harvard University; culinary scientist Ali Bouzari, PhD; Fabrice DeClerck, PhD, chief science officer, EAT Foundation; David Eisenberg, MD, director of culinary nutrition and
More news about: The Culinary Institute of America
May 28, 2026, 09:15 ET Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research
participating in early access and evidence generation for a tumor-informed, non-bespoke whole-genome sequencing approach to MRD," said Gang Zheng, MD, PhD and professor of Laboratory Medicine and Pathology at Mayo Clinic. "We have seen early pilot results across several solid tumor clinical samples that demonstrated
More news about: Illumina, Inc.
May 28, 2026, 09:06 ET Theranica Advances Nerivio® as a Transformative Therapy for Personalized Migraine Care
algorithm will be featured at the upcoming American Headache Society Scientific Meeting in Orlando, Florida, June 4-6, 2026, when Peter Goadsby, MD, PhD, DSc, FRS, FAHS, King Abdullah University of Science and Technology, Saudi Arabia, is scheduled to discuss the clinical relevance of this new capability
More news about: Theranica
May 28, 2026, 09:02 ET Weihai Medison Launches VEMERIX, Anchoring Its Minimally Invasive Surgery Platform on a Korea Joint Research Institute
injection devices.Underpinning the platform is the Medison Korea Joint Research Institute, a multidisciplinary R&D arm collaborating with senior PhD researchers from Seoul National University, Yonsei University, PNS Precision Research Institute and MFC Research Institute. The institute's development
More news about: WEIHAI MEDISON (VEMERIX brand)
May 28, 2026, 09:00 ET Teal Health and WashU Medicine Collaborate to Expand Cervical Cancer Screening in Underserved Communities
us a real-world lens into what it takes to reach women who've fallen through the cracks of the traditional screening system," says Michelle Silver, PhD, ScM, an epidemiologist and health services research member at Siteman and associate professor in the Division of Public Health Sciences at WashU Medicine.
More news about: Teal Health